Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets
Report Highlights
The global market for over the counter (OTC) drugs and dietary supplements reached $164.7 billion in 2016 and should reach $220.8 billion in 2021, with a compound annual growth rate (CAGR) of 6.0%.
Report Includes
- An overview of the global markets for OTC drugs and dietary supplements
- Analyses of global market trends, with data from 2015, 2016, and projections of CAGRs through 2021
- Information about how pharmacies affect the OTC drug market
- Analysis of new developments that will provide an opportunity to manufacturers and marketers of OTC medicines and dietary supplements to expand organically
- Updates on the latest merger and acquistion activity
- Coverage of how point of sales and channels of distribution drive sales of OTC drugs and dietary supplements
- A look at key strategic initiatives for market penetration and expansion
- Company profiles of major players in the field
Report Scope
The report considers only western or modern drugs for this report and excludes any other type of drugs such as alternative therapies.
This study aims at understanding the dynamics and forecasts for OTC drugs and dietary supplements markets worldwide and provides key market propositions within the next five-year period.
The report covers developed and emerging markets in order to help readers understand:
- The current state of the OTC drugs and dietary supplements market and the key markets for its future development.
- New regulations that will influence the development of the OTC drugs and dietary supplements market.
- Market drivers of and threats to the OTC drugs and dietary supplements industry.
- Major regional trends in the global OTC drugs and dietary supplements market.
Frequently Asked Questions (FAQs)
Analyst Credentials
Anand Gijare has over 20 years of experience in consumer healthcare medicines and products. He has helped companies conduct research on product developments, competitive market analysis, consumer behavior analysis and supply chain dynamics in consumer healthcare. His key focus has been studying marketing strategies in consumer healthcare, and he provides precise consultation on the gaps between market's hidden desires and available opportunities. He is proficient in identifying opportunities for new products in consumer healthcare-based on integration of advanced technologies and smart materials.
Report Highlights
The global market for OTC medicines and dietary supplements reached $128.8 billion in 2012. This market is expected to reach to $142.7 billion in 2013 and $189.7 billion in 2018, with a compound annual growth rate (CAGR) of 5.9%.
Report Includes
- An overview of the global market for OTC drugs and dietary supplements.
- Analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.
- Information about how pharmacies affect the OTC drug market
- Updates on the latest merger and acquistion activity
- Company profiles of major players in the market
Report Highlights
-
In 2005, the herbal supplements market for products covered in this report was only 0.47% of the prescription market for drugs to treat these conditions. It is unlikely that the herbal supplements market will ever represent more than a very small percentage of the prescription drug market. For those categories where OTC products exist-treatments for nausea, heartburn and insomnia-OTC revenues represented 4.3%, 14.2% and 7.2% of prescription drug markets for these categories, respectively, in 2005.
-
The global market for herbal supplements covered in this report was $5.5 billion in 2005 and $5.6 billion by the end of 2006. Growing at an average annual growth rate (AAGR) of 1.7%, this market sector will cross just over $6.1 billion by 2011.
-
The global market for prescription drugs was worth more than $114 billion in 2005 and almost $120 billion in 2006. At an AAGR of 4.6%, this market will grow to reach almost $150 billion by 2011.